Projects By Region: Asia
Stay up to date with the project updates from Asia.Latest Industry Projects In Asia
Myrbetriq (mirabegron) is a beta-3 adrenergic agonist indicated for the treatment of the overactive bladder (OAB) condition. It was developed by Japan's Astellas...
Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat...
Halaven is a non-taxane drug developed by Eisai Co. for the treatment of metastatic breast...
Fycompa (perampanel / E2007) is an AMPA-type glutamate receptor antagonist indicated for the treatment of epilepsy. It was developed by Japan-based healthcare company...